$AME

AMETEK, Inc. (AME) Raises 2026 Adjusted EPS Guidance to $8.53–$8.57

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, with adjusted EPS of $2.21, also up 17%. The company raised its 2026 adjusted EPS guidance to $8.53–$8.57 from $8.20–$8.30, citing strong performance.

Original reporting
Published Nov 3, 2026, 11:55 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 12:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMETEK, Inc. (AME) Raises 2026 Adjusted EPS Guidance to $8.53–$8.57 — source image
Decision brief

The 30-second read

$AMEBullishMed
01

Why it matters

The key tradable input is the raised 2026 adjusted EPS guidance range, which can drive estimate revisions and re-rating versus peers if investors view it as durable.

02

Market read

Traders can update 2026 earnings expectations and positioning based on the guidance increase and the stated Q3 performance backdrop.

03

What to watch

The article provides no segment detail or margin drivers, so traders may need to verify whether the raise is driven by sustainable demand versus temporary cost or mix effects.

Relevance 9/10Novelty 8/10Timing: guidance update reported during the trading day (published 2026-11-03 11:55 UTC)

Background

The piece summarizes AMETEK’s Q3 2026 results and a raised full-year adjusted EPS outlook, citing record sales and higher adjusted EPS.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

AMETEK raised 2026 adjusted EPS guidance to $8.53–$8.57 from $8.20–$8.30, following Q3 sales of $2.22B and adjusted EPS of $2.21.

Expected impact

Likely upward pressure as the market reprices 2026 earnings expectations toward the raised guidance range.

Evidence & confidence

The article discloses a specific, company-issued full-year adjusted EPS guidance increase with concrete Q3 performance context.

Market effects

Supports the broader industrial/automation earnings narrative by indicating resilient demand and margin/earnings delivery.

Primarily US large-cap sentiment impact via AMETEK’s guidance update.

Limited direct global spillover beyond industrial earnings expectations.

Counterpoint

A guidance raise can still be met with selling if the market had already priced in a similar or higher outcome, or if Q4 margin assumptions are questioned.

Key entities

  • AMETEK, Inc.

    Raised 2026 adjusted EPS guidance to $8.53–$8.57 from $8.20–$8.30 after Q3 results.

Related articles

$AMEHighAI 9/10

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 8/10

AMETEK Boosts FY26 Outlook - Update

AMETEK (AME) reported Q3 results and raised its FY26 outlook. Q4 adjusted earnings are expected to be $2.26-$2.30 per share with net sales growth in the low 20% range. FY26 adjusted earnings are now projected to be $8.53-$8.57 per share with mid-teen percentage net sales growth, up from previous guidance of $8.20-$8.30 per share. AME stock is up 0.86% in pre-market trading.

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.